You can watch the video here: https://youtu.be/EidtofNk264
Context : Supplementary Question
M. Peter Julian (New Westminsterâ€”Burnaby, NPD): Monsieur le PrÃ©sident, un autre jour, un autre conflit d'intÃ©rÃªts est lÃ . On a encore l'implication du sacrÃ© Morneau Shepell. Ce qui est clair, c'est qu'ils n'ont jamais eu l'intention de voler l'idÃ©e du NPD d'un programme national complet d'assurance-mÃ©dicament. Les libÃ©raux veulent plutÃ´t saboter cette idÃ©e. Voler nos idÃ©es, Ã§a va aider les gens, mais saboter nos idÃ©es, jamais.
Pourquoi les intÃ©rÃªts des familles canadiennes passent-ils toujours derriÃ¨re les intÃ©rÃªts de Morneau Shepell et des super riches?
Hon. Bill Morneau (Minister of Finance, Lib.): Mr. Speaker, that is a bizarre question. We think that the idea of actually having experts help us to come forward with a way that we can get pharmaceuticals to all Canadians is important.
I guess members opposite would have us not have experts involved. I can tell the member what would happen if that were the case. We could have the NDP and the member for Carleton do the policy, because that way we would have no expertise at all.
Mr. Peter Julian (New Westminsterâ€”Burnaby, NDP): Mr. Speaker, they are not going to wait another 21 years because of Liberal waiting.
Liberals promised yet another study one day and then literally the next day admitted that they have no intention of every bringing in universal pharmacare. The PBO says that Canadians would save over $4 billion per year. Hundreds of thousands of Canadians who cannot afford medication would be helped, and businesses would be helped by reducing costs. The only one not helped is Morneau Shepell. We need to act.
The Prime Minister has not stolen the NDP plan, he has vandalized it. Why won't the government bring in real universal pharmacare now?
Hon. Ginette Petitpas Taylor (Minister of Health, Lib.): Mr. Speaker, Canadians are proud of our publicly-funded universal medicare system, one based on the individual's need and not the ability to pay. Yet, we recognize that there is certainly room for improvement.
We have created a national advisory committee on the implementation of pharmacare with its mandate to study, evaluate, and ultimately bring recommendations to government on possible options. This initiative will build on the good work that has already been started by the HESA committee, and we look forward to the report that we will be receiving next spring.